How did MLEC's revenue and expenses trend in Q1 2025?

**Moolec Science's revenue and expenses in Q1 2025 reflect a challenging financial period for the company.** Here's a detailed analysis: 1. **Revenue Decline**: Moolec Science experienced a decline in revenue from the previous quarter's $1,740,050 in 2023 to $1,557,002 in 2024 for the three months ending September 30. This indicates a reduction in the company's earnings during this period. |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |MLEC|MLEC.O|Moolec Science SA|2024 Q2||252114|186| |MLEC|MLEC.O|Moolec Science SA|2024 Q3||2109859|186| |MLEC|MLEC.O|Moolec Science SA|2024 Q4|68.29834254143647|1523100|186| |MLEC|MLEC.O|Moolec Science SA|2025 Q1|-10.519697709835924|1557002|186| |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |MLEC|MLEC.O|Moolec Science SA|2024 Q2|96.28130636889489|-1783517|186| |MLEC|MLEC.O|Moolec Science SA|2024 Q3|-291.05271377496666|-1402229|186| |MLEC|MLEC.O|Moolec Science SA|2024 Q4|7.743250127356088|-2535400|186| |MLEC|MLEC.O|Moolec Science SA|2025 Q1|-20.395687500274985|-1915499|186| 2. **Operating Expenses**: The data does not provide specific information about MLEC's operating expenses in Q1 2025. However, the company's financial statements for the period ending September 30, 2024, revealed a comprehensive loss of $1,408,157 for the same period in 2024. This loss suggests that the company's expenses were likely higher than its revenue during this quarter. 3. **Net Income**: The net income for MLEC in Q1 2025 is not available. However, the company reported a comprehensive loss for the period ending September 30, 2024, which implies that the net income for Q1 2025 was negative. 4. **Challenging Financial Position**: The overall financial position of Moolec Science in Q1 2025 was challenging, with a decline in revenue and a significant loss. This could be indicative of operational inefficiencies or market conditions affecting the company's financial performance. In summary, Moolec Science faced a difficult financial quarter in Q1 2025, characterized by a decline in revenue and a substantial loss. The company's financial performance appears to be under strain, which could be a concern for investors and stakeholders.